Novel antibody capture assay for paraffin-embedded tissue detects wide-ranging amyloid beta and paired helical filament-tau accumulation in cognitively normal older adults

Brain Pathology

Volumn 22, Issue 4, 2012, Pages 472-484

  Postupna, Nadia ^a   Rose, Shannon E ^a   Bird, Thomas D ^a,b   Gonzalez Cuyar, Luis F ^a   Sonnen, Joshua A ^a   Larson, Eric B ^c   Keene, C Dirk ^a   Montine, Thomas J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

Author keywords

Aging; Alzheimer's disease; ELISA; Immunohistochemistry

Indexed keywords

AMYLOID BETA PROTEIN; PARAFFIN; PROTEINASE K; SYNAPTOPHYSIN; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTELIDE GLASS SLIDE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MALE; PAIRED HELICAL FILAMENT; PREFRONTAL CORTEX; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; TISSUE SECTION;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BRAIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PARAFFIN EMBEDDING; TAU PROTEINS;

EID: 84861554583     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2011.00542.x     Document Type: Article

References (41)

1. Alafuzoff I, Thal DR, Arzberger T, Bogdanovic N, Al-Sarraj S, Bodi I et al (2009) Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:309-320.
2. Allen CT, Sonnen J, Leslie MJ, Kidoguchi L, Harris C, Gambetti P, Montine TJ (2007)Washington statewide pathology surveillance for prion disease. Ann Neurol 61:371-372. (Pubitemid 46676736)
3. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM et al (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152:879-884. (Pubitemid 28173348)
4. Berti V, Pupi A, Mosconi L (2011) PET/CT in diagnosis of dementia. Ann NY Acad Sci 1228:81-92.
5. Biernat J, Mandelkow EM, Schroter C, Lichtenberg-Kraag B, Steiner B, Berling B et al (1992) The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J 11:1593-1597.
6. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259.
7. Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA et al (2011) Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA 305:275-283.
8. Counts SE, Nadeem M, Lad SP,Wuu J, Mufson EJ (2006) Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. J Neuropathol Exp Neurol 65:592-601. (Pubitemid 44288943)
9. Dabbs DJ (2010) Diagnostic Immunohistochemistry, 3rd edn. Saunders: Philadelphia.
10. de la Monte SM, Ganju N, Wands JR (1999) Microtiter immunocytochemical ELISA assay. Biotechniques 26:1073-1076, 1078.
11. Esiri MM, Hyman BT, Beyreuther K, Masters C (1997) Aging and dementia. In: Greenfield's Neuropathology, 6th edn. DI Graham, PL Lantos (eds), pp. 153-233. Arnold Publishing: London.
12. Forman MS, Mufson EJ, Leurgans S, Pratico D, Joyce S, Leight S et al (2007) Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis. Neurology 68:757-763. (Pubitemid 46667901)
13. Haneuse S, Schildcrout J, Crane P, Sonnen J, Breitner J, Larson E (2009) Adjustment for selection bias in observational studies with application to the analysis of autopsy data. Neuroepidemiology 32:229-239.
14. Harlow E, Lane D (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press: NewYork.
15. Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095-1097.
16. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW et al (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9:119-128.
17. Khatoon S, Grundke-Iqbal I, Iqbal K (1994) Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Lett 351:80-84. (Pubitemid 24268070)
18. Kim KS, Miller DL, Sapienza VJ, Chen CMJ, Bai C, Grundke-Iqbal I et al (1988) Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun 2:121-130.
19. Lee VM, Balin BJ, Otvos L Jr, Trojanowski JQ (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251:675-678. (Pubitemid 21916893)
20. Leuba G, Savioz A, Vernay A, Carnal B, Kraftsik R, Tardif E et al (2008) Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD-95 postsynaptic protein. J Alzheimers Dis 15:139-151.
21. Leverenz JB, Hamilton R, Tsuang DW, Schantz A, Vavrek D, Larson EB et al (2008) Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol 18:220-224. (Pubitemid 351430400)
22. Maarouf CL, Daugs ID, Kokjohn TA, Kalback WM, Patton RL, Luehrs DC et al (2010) The biochemical aftermath of anti-amyloid immunotherapy. Mol Neurodegener 5:39.
23. Masliah E, Terry RD, Alford M, DeTeresa R, Hansen LA (1991) Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. Am J Pathol 138:235-246.
24. Mc Donald JM, Savva GM, Brayne C, Welzel AT, Forster G, Shankar GM et al (2010) The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain 133:1328-1341.
25. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486.
26. Mitchell TW, Mufson EJ, Schneider JA, Cochran EJ, Nissanov J, Han LY et al (2002) Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann Neurol 51:182-189. (Pubitemid 34111440)
27. Mukaetova-Ladinska EB, Garcia-Siera F, Hurt J, Gertz HJ, Xuereb JH, Hills R et al (2000) Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. Am J Pathol 157:623-636. (Pubitemid 30626921)
28. Nelson PT, Abner EL, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD et al (2010) Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol 20:66-79.
29. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A et al (1995) Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med 333:1242-1247.
30. Reddy PH, Mani G, Park BS, Jacques J, Murdoch G, Whetsell W et al (2005) Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. J Alzheimers Dis 7:103-117, discussion 173-180.
31. Roth KA, Brenner JW, Selznick LA, Gokden M, Lorenz RG (1997) Enzyme-based antigen localization and quantitation in cell and tissue samples (Midwestern assay). J Histochem Cytochem 45:1629-1641. (Pubitemid 27527903)
32. Schneider JA, Aggarwal NT, Barnes L, Boyle P, Bennett DA (2009) The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis 18:691-701.
33. Schulz-Schaeffer WJ, Tschoke S, Kranefuss N, Drose W, Hause-Reitner D, Giese A et al (2000) The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 156:51-56. (Pubitemid 30644438)
34. Shirao T, Obata K (1986) Immunochemical homology of 3 developmentally regulated brain proteins and their developmental change in neuronal distribution. Brain Res 394:233-244. (Pubitemid 16017082)
35. Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD et al (2007) Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 62:406-413. (Pubitemid 350105954)
36. Sonnen JA, Larson EB, Haneuse S, Woltjer R, Li G, Crane PK et al (2009) Neuropathology in the adult changes in thought study: a review. J Alzheimers Dis 18:703-711.
37. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM et al (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:280-292.
38. Walsh DM, Selkoe DJ (2007) A beta oligomers - a decade of discovery. J Neurochem 101:1172-1184.
39. White L (2009) Brain lesions at autopsy in older Japanese-American men as related to cognitive impairment and dementia in the final years of life: a summary report from the Honolulu-Asia aging study. J Alzheimers Dis 18:713-725.
40. Woltjer RL, Sonnen JA, Sokal I, Rung LG, Yang W, Kjerulf JD et al (2009) Quantitation and mapping of cerebral detergent-insoluble proteins in the elderly. Brain Pathol 19:365-374.
41. Wong CW, Quaranta V, Glenner GG (1985) Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc Natl Acad Sci U S A 82:8729-8732. (Pubitemid 16101117)